Nayaa Lacy
⚠️ Moderate Risk
FEI: 3004111954 • Curepe • TRINIDAD AND TOBAGO
FEI Number
3004111954
Location
Curepe
Country
TRINIDAD AND TOBAGOAddress
8 Fraser Street, , Curepe, , Trinidad and Tobago
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 9/21/2003 | 64HBL99EXPECTORANT N.E.C. | 16DIRECTIONS | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Nayaa Lacy's FDA import refusal history?
Nayaa Lacy (FEI: 3004111954) has 1 FDA import refusal record(s) in our database, spanning from 9/21/2003 to 9/21/2003.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Nayaa Lacy's FEI number is 3004111954.
What types of violations has Nayaa Lacy received?
Nayaa Lacy has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Nayaa Lacy come from?
All FDA import refusal data for Nayaa Lacy is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.